Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-026116
Filing Date
2025-09-02
Accepted
2025-09-02 06:06:16
Documents
1
Period of Report
2025-09-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5834
  Complete submission text file 0001641172-25-026116.txt   7461
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address NO. 28, JALAN EKOFLORA 1/13 TAMAN EKOFLORA, 81100 JOHOR BAHRU JOHOR Malaysia 00000
Business Address
Kua Khai Loon (Reporting) CIK: 0002081556 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 251282807